These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9773750)

  • 1. Chorea in hyperglycemia.
    Piccolo I; Sterzi R; Thiella G
    Diabetes Care; 1998 Oct; 21(10):1777. PubMed ID: 9773750
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 4. Glyburide/metformin (Glucovance) for type 2 diabetes.
    Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of diabetes in cardiovascular patients: diabetic heart disease.
    Peter R; Cox A; Evans M
    Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822
    [No Abstract]   [Full Text] [Related]  

  • 7. Teaching Video NeuroImages: hemichorea-hemiballismus secondary to nonketotic hyperglycemia.
    Vale TC; Freitas Dda S; Maciel RO; Miranda EC; Cardoso F
    Neurology; 2013 Apr; 80(16):e178. PubMed ID: 23589647
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA; Darby-Stewart A; Dachs R
    Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient characteristics not described.
    Lofsky S
    CMAJ; 2006 Jun; 174(13):1874. PubMed ID: 16785468
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin in the UKPDS study. Metabolic and vascular results].
    Basin C; Isnard F
    Journ Annu Diabetol Hotel Dieu; 1999; ():243-61. PubMed ID: 10732421
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
    Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
    Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Woo V;
    Diabetes Care; 2009 Mar; 32(3):e34; author reply e37-8. PubMed ID: 19246585
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coma in type 2 diabete mellitus on metformin treatment].
    Renard C; Tellal S; Fevre G; Ragot C; Vest P; Foissaud V; Renaudeau C
    Ann Biol Clin (Paris); 2003; 61(1):84-7. PubMed ID: 12604391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L; Uusitupa M; Laakso M
    Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract]   [Full Text] [Related]  

  • 19. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B; Abreu-Pacheco H
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
    Kahn SE; Zinman B; Lachin JM; Haffner SM; Herman WH; Holman RR; Kravitz BG; Yu D; Heise MA; Aftring RP; Viberti G;
    Diabetes Care; 2008 May; 31(5):845-51. PubMed ID: 18223031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.